Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00794677 · ClinicalTrials.gov registry record · Phase 4
Effects of Ezetimibe on the Absorption of Oxidized Cholesterol
A Phase 4 study, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT00794677: Completed Phase 4 study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT00794677 is a Phase 4 study that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00794677, a Phase 4 study, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effects of Zetia™ (ezetimibe) 10 milligrams (mg) on the absorption of oxysterol into the blood following a meal containing oxysterol.
Interventions
- DRUG placebo
- DRUG ezetimibe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00794677
The ClinicalTrials.gov registry entry for NCT00794677 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCSF Benioff Children's Hospital Oakland, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00794677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00794677 about?
NCT00794677 is a clinical study titled "Effects of Ezetimibe on the Absorption of Oxidized Cholesterol". The purpose of this study is to test the effects of Zetia™ (ezetimibe) 10 milligrams (mg) on the absorption of oxysterol into the blood following a meal containing oxysterol.
What is the current status of trial NCT00794677?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2006-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00794677?
The interventions under investigation include: placebo (DRUG), ezetimibe (DRUG).
Who is sponsoring clinical trial NCT00794677?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.